Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PB Fintech Limited Board/Management Information 2021

Nov 30, 2021

61288_rns_2021-11-30_01225986-64da-46de-8063-64ed8292a62f.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

November 30, 2021

To

Department of Corporate Services/ Listing Department of Corporate Services/ Listing National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5" Floor, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, : Dalal Street, Fort, Bandra-Kurla Complex, Mumbai — 400001 Bandra (East), Mumbai — 400051 Scrip Code: 543390 Symbol: POLICYBZR

Sub: Outcome of Board Meeting held today i.e. November 30, 2021 pursuant to Regulation 30 of the Securities_and_ Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015

Dear Sir / Madam,

This is to inform you that pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Board of Directors of the Company in its Meeting held today i.e. Tuesday, November 30, 2021, at 04:00 P.M. (IST) and concluded at 05:00 P.M. (IST) inter alia considered and approved the following:

  • (i) Further investment of = 10,80,94,228/ (Rupees Ten Crore Eighty Lakh Ninety Four Thousand Two Hundred Twenty Eight Only) by Docprime Technologies Private Limited ("Docprime') a wholly owned subsidiary of the company in Visit Health Private Limited ("WHPL") and in lieu VAHPL will issue 1,44,511 Compulsorily Convertible Debentures ("CCD's") of = 748 each to Docprime. Details in respect of the same are enclosed herewith as Annexure A.
  • (ii) Approved the list of eligible employees of the Company and its subsidiaries to whom. 24,32,500 stock options and 1,54,94,500 stock options would be vested on December 01, 2021 under the Employee Stock Option Plan 2014 ("ESOP 2014") -and Employee Stock Option Plan 2020 ("ESOP 2020") respectively, subject to they being the employee of the Company and its subsidiaries as on the vesting date.

Further, Disclosure as required under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with events specified in Part A of Schedule III and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 is annexed herewith.

You are requested to kindly take the same in your records.

Thanking you

Yours Sincerely For PB Fintech Limited (Formerly PB Fintech Thy imited/ Etechaces Marketing and Consulting Private Limited)

Bhasker Joshi q Company Secretary and e Officer Mem. No.: F8032

Wea in Mm

Encl.: A/a

PB FINTECH LIMITED

.(Formerly Known As Etechaces Marketing And Consulting Private Limited) Registered Office Address : Plot No. 119, Sector-44, Gurugram-122001 (Haryana) Telephone No. : 0124-4562900, Fax : 0124-4562902 E-mail : [email protected] Website : www.pbfintech.in CIN : U51909HR2008PLC037998

Annexure-A

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read with the events specified in Para A(1) of Part A of Schedule III and SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 relating to Continuous Disclosure Requirements for Listed Entities.

pb
\Euntech/
Annexure-A
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 read
with the events specified in Para A(1) of Part A of Schedule III and SEBI Circular No. CIR/CFD/CMD/4/2015
dated September 9, 2015 relating to Continuous Disclosure Requirements for Listed Entities.
SL Particulars Details
No.
1.
Name of the target entity, details in brief Visit Health Private Limited ("VHPL")
such as size, turnover etc. Registered Office: Building No. 237, Okhla Industrial
Estate Phase 3, New Delhi 110020
Authorised Capital:
= 1,00,01,000 (Rupees One Crore One Thousand Only)
Issued & Paid up Capital:
Two
(INR
Lakh
85,62,600
Eighty
Five
Sixty
%
Thousand Six Hundred Only)
Turnover:
% 8,91,29,282 ( Rupees Eight Crore Ninety
One Twenty Nine Thousand Two Hundred Eighty Two
Only) as at 31°* March,2021
2s Whether the acquisition would fall within
related party transaction(s) and whether the
group/ — group
promoter/
promoter
companies have any interest in the entity
being acquired? If yes, nature of interest
and details thereof and whether the same is
done at "arms length"
As VHPL is an associate company, it is related party of
the company.
The company is professionally managed company with
no identifiable Promoter.
The transaction is done on the basis of a valuation
report obtained and is at arm's length.
uo Industry to which the entity being acquired
belongs
Telehealth and wellness platform
4. Objects and effects of acquisition (including
but not limited to, disclosure of reasons for
acquisition of target entity, if its business is
outside the
main
line of business
of the
listed entity)
Docprime is making further investment in Visit Health
Private Limited to acquire a minority stake as part of
strategic investments and in terms of the Shareholders
Agreement
September
2021
entered
dated
into
10,
between Docprime, VHPL and others.
5. Brief
governmental
any
details
of
approvals
regulatory
required
the
for
acquisition
or Not Applicable
6. Indicative time period for completion of the Within 6 (six) Months
acquisition
7. Nature
whether
consideration
of
-
consideration or share swap and details of
the same
cash Cash Consideration
AEEHY

paisabazaar@" QuickFIXcars

PB FINTECH LIMITED

(Formerly Known As Etechaces Marketing And Consulting Private Limited) Registered Office Address : Plot No. 119, Sector-44, Gurugram-122001 (Haryana) Telephone No. : 0124-4562900, Fax : 0124-4562902 E-mail : [email protected] Website : www.pbfintech.in CIN : U51909HR2008PLC037998

pb
Cost of acquisition or the price at which the
shares/ compulsorily convertible debentures
("CCDs") are acquired
VHPL will issue 1,44,511
Compulsorily Convertible
Debentures ("CCDs") of % 748 each to Docprime for
investment amount of 2
aggregate
10,80,94,228
an
(Rupees
Lakhs
Ninety-Four
Ten
Crores
Eighty
Thousand Two Hundred and Twenty-Eight Only).
Percentage
shareholding
control
of
/
number
acquired
and
shares/
or
of
/
Compulsorily Convertible Debentures
("CCDs") acquired
Percentage of Shareholding of Docprime: 30.46% on a
fully diluted basis.
10 Brief background about the entity acquired
terms
products/line
business
of
of
in
acquired, date of incorporation, history of
last 3 years turnover, country in which the
acquired entity has presence and any other
significant information (in brief)
VISIT HEALTH PRIVATE LIMITED, a company
incorporated under the laws of India on 03",May 2018,
having CIN U72200DL2018PTC333356 and having its
registered office at Building No. 237, Okhla Industrial
Estate Phase 3, New Delhi 110020, India, is engaged in
of providing
wellness
business
healthcare
and
the
services through the website and the mobile application
and the access to medical services of diagnostics, OPD,
pharmacy through its network partners and health risk
assessment to the subscribers / customers.
Turnover of VHPL for last 3 years:
F.-Y. 2020-21: INR 8,91,29,282
F.Y. 2019-20: INR 2,50,38,422
F.Y. 2018-19: INR 1,19,68,930

policybazaar@)

PB FINTECH LIMITED

(Formerly. Known As Etechaces Marketing And Consulting Private Limited) Registered Office Address : Plot No. 119, Sector-44, Gurugram-122001 (Haryana) Telephone No. : 0124-4562900, Fax : 0124-4562902 E-mail : [email protected] Website : www.pbfintech.in CIN : U51909HR2008PLC037998